Musculoskeletal Pain & Structural Health Support

Restoring Movement. Releasing Pain.

The musculoskeletal system gives the body its structure, mobility, and strength. When joints, tendons, ligaments, or muscles are compromised, pain emerges — and movement becomes progressively limited. Over time, inflammation and degeneration can turn acute discomfort into chronic dysfunction that resists conventional management.

At Blast Institute, we approach pain not as something to suppress, but as a signal of tissue imbalance that can be addressed at its biological source — through regenerative repair, reduced inflammation, and structural restoration.

What Drives Musculoskeletal Dysfunction

Chronic Joint Inflammation

Persistent synovial inflammation degrades cartilage, erodes joint surfaces, and creates the pain-inflammation cycle characteristic of osteoarthritis and inflammatory joint conditions.

Tissue degeneration & impaired repair

Reduced regenerative capacity — particularly in avascular tissues like cartilage and tendon — means damage accumulates faster than the body can address it, accelerating structural deterioration.

Muscle loss & structural instability

Sarcopenia and muscle atrophy reduce the structural support around joints, increasing mechanical load on cartilage and connective tissue and compounding degenerative processes.

Systemic inflammatory burden

Metabolic dysfunction, gut permeability, and circulating inflammatory mediators maintain a systemic state that perpetuates local joint and tissue damage regardless of local treatment alone.

Systemic IV Infusions

Address the inflammatory, metabolic, and regenerative environment system-wide — improving the conditions that allow local tissue to heal and stay healed.

Targeted Local Delivery

Intra-articular or peri-lesional exosome delivery concentrates regenerative signals directly at the site of damage — accelerating cartilage, tendon, and tissue repair where it is most needed.

Technology

Role in Musculoskeletal Repair

Key Signals

Pluripotent Stem Cells

PSC · SYSTEMIC

Deliver adaptive signaling that reduces joint and systemic inflammation, supports cartilage and connective tissue repair, and improves vascular supply to damaged musculoskeletal structures. Broad exosomal cargo includes signals relevant to both the mesodermal tissues at the core of musculoskeletal pathology and the neural pain pathways that sustain chronic pain states.Deliver adaptive signaling that reduces joint and systemic inflammation, supports cartilage and connective tissue repair, and improves vascular supply to damaged musculoskeletal structures. Broad exosomal cargo includes signals relevant to both the mesodermal tissues at the core of musculoskeletal pathology and the neural pain pathways that sustain chronic pain states.

Pluripotent Exosomes

EXOSOMAL · IV + LOCAL

Delivered intravenously for systemic effect and — where clinically indicated — by direct intra-articular or peri-lesional injection for localized repair. Local delivery achieves substantially higher concentrations of regenerative signals at the target site, enhancing matrix synthesis, reducing local inflammation, and accelerating tissue remodeling. Local delivery route and frequency are determined by the treating physician.Delivered intravenously for systemic effect and — where clinically indicated — by direct intra-articular or peri-lesional injection for localized repair. Local delivery achieves substantially higher concentrations of regenerative signals at the target site, enhancing matrix synthesis, reducing local inflammation, and accelerating tissue remodeling. Local delivery route and frequency are determined by the treating physician.

Follistatin Minicircle Therapy

GENE THERAPY

Skeletal muscle is the primary structural support system for every joint in the body. Follistatin promotes muscle regeneration by inhibiting myostatin, a negative regulator of muscle development. Sustaining or rebuilding muscle mass around compromised joints reduces mechanical load on cartilage and connective tissue, supports stability, and improves long-term functional outcomes. Delivered via minicircle DNA for 8–14 months of sustained expression.

Local application options

TARGETED DELIVERY · CLINICIAN-DETERMINED · ADJUNCT TO SYSTEMIC PROTOCOL

Intra-Articular Exosome Injection

Direct delivery into affected joints — knees, hips, shoulders, hands — achieving high local concentrations for cartilage repair, synovial inflammation reduction, and joint function restoration.

Peri-Tendinous & Ligament Injection

Targeted delivery around tendon and ligament injuries to accelerate collagen remodeling, reduce fibrosis, and restore tensile integrity — particularly relevant for chronic tendinopathies.

Spinal & Disc Applications

Peri-discal and facet joint delivery addressing disc degeneration, spinal inflammation, and nerve root irritation — supporting structural and functional spinal recovery.

Ozone Therapy (Local)

Intra-articular or peri-lesional ozone as a complementary modality — reducing local inflammation, improving oxygen delivery to avascular tissues, and enhancing the environment for regenerative repair.

How the Musculoskeletal Protocol Works

Systemic Terrain Preparation

Systemic terrain preparation Ozone apheresis and IV protocols reduce systemic inflammatory burden — addressing circulating mediators that sustain local joint and tissue inflammation. Nutritional deficiencies contributing to impaired tissue repair are assessed and corrected.

Pulsed Daily IV Infusions

Each session delivers adaptive anti-inflammatory and regenerative signals calibrated to the patient's evolving state. Cumulative infusions progressively reduce inflammatory load, improve vascular supply to damaged structures, and create the biological conditions for tissue repair.

Local Applications (Where Indicated)

At the clinician's discretion, targeted injections of exosomes and/or ozone are administered to specific joints, tendons, spinal structures, or injury sites — concentrating regenerative signals where structural damage is most significant. Timing and frequency are determined individually.

Gene Therapy Extension (Optional)

Where muscle preservation or structural support is a clinical priority, Follistatin minicircle therapy at program completion provides 8–14 months of continued muscle-building and joint-stabilizing support — sustaining the structural gains achieved during the in-clinic program.

Progressive Structural Recovery

Pain reduction, improved range of motion, and functional recovery develop progressively as inflammation resolves, tissue repair accumulates, and structural stability is restored. Results in cartilage and tendon — both avascular, slow-repair tissues — typically develop over weeks to months.

Pain is local. Its causes are often not.

gut permeability all influence tissue repair. Treating only the joint without addressing the broader biological environment limits the depth and durability of recovery.

Precision and reach, together.

Our approach combines the systemic reach of IV regenerative therapy with the anatomical precision of targeted local delivery — addressing both the site of damage and the conditions that perpetuate it.

Musculoskeletal Conditions We Address

Joint Pain & Osteoarthritis

Cartilage · Synovial · Degenerative

Tendon & Ligament Injuries

Collagen · Repair · Chronic tendinopathy

Sports Injuries

Acute · Post-injury · Recovery

Spine & Disc Conditions

Disc · Facet · Nerve root

Chronic Musculoskeletal Pain

Persistent · Multi-site · Fibromyalgia

Bone Fractures Support

Fracture repair · Delayed union · Bone density

Strength is not only built — it is restored. Movement is not only regained — it is refined. At Blast Institute, we design the conditions for both — working at the level of cellular repair, structural biology, and systemic inflammation to give the musculoskeletal system what it needs to recover fully and durably.